Cryoport, Inc. (CYRX)

Market Cap	373.02M
Revenue (ttm)	232.13M
Net Income (ttm)	-115.84M
Shares Out	50.14M
EPS (ttm)	-2.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	422,582
Open	7.39
Previous Close	7.31
Day's Range	7.34 - 7.54
52-Week Range	4.58 - 9.78
Beta	1.84
Analysts	Strong Buy
Price Target	10.75 (+44.1%)
Earnings Date	Aug 5, 2025

About CYRX

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company’s Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company’s products include Cryoport Express Shippers; Cryoport ELITE Shi...

• Industry: Integrated Freight & Logistics
• Sector: Industrials
• Founded: 1999
• Employees: 1,105
• Stock Exchange: NASDAQ
• Ticker Symbol: CYRX
• Website: https://www.cryoportinc.com

Financial Performance

In 2024, Cryoport's revenue was $228.39 million, a decrease of -2.09% compared to the previous year's $233.26 million. Losses were -$122.76 million, 14.1% more than in 2023.

Analyst Summary

According to 8 analysts, the average rating for CYRX stock is "Strong Buy." The 12-month stock price target is $10.75, which is an increase of 44.10% from the latest price.

Price Target

$10.75

(44.10% upside)

Analyst Consensus: Strong Buy